共 50 条
- [21] Re: Logan G. Briggs, Chanan Reitblat, Paul A. Bain, et al. Prehabilitation Exercise Before Urologic Cancer Surgery: A Systematic and Interdisciplinary Review. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.05.015 Strategies for Effective Prehabilitation in Urologic Cancer [J]. EUROPEAN UROLOGY, 2021, 80 (06) : E139 - E140
- [22] Re: Alonso Garcia-Ruiz, Carlos Macarro, Francesca Zacchi, et al. Whole-body Magnetic Resonance Imaging as a Treatment Response Biomarker in Castration-resistant Prostate Cancer with Bone Metastases: The iPROMET Clinical Trial. Eur Urol. In press. https://doi.org/10.1016/j. eururo.2024.02.016 [J]. EUROPEAN UROLOGY, 2024, 86 (03) : e67 - e68
- [23] Re: Gabriela Ilie, Ricardo Rendon, Ross Mason, et al. A Comprehensive 6-mo Prostate Cancer Patient Empowerment Program Decreases Psychological Distress Among Men Undergoing Curative Prostate Cancer Treatment: A Randomized Clinical Trial. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2023.02.009 [J]. EUROPEAN UROLOGY, 2023, 84 (01) : E24 - E25
- [24] Re: R. Jeffrey Karnes, Voleak Choeurng, Ashley E. Ross, et al. Validation of a Genomic Risk Classifier to Predict Prostate Cancer-specific Mortality in Men with Adverse Pathologic Features. Eur Urol. In press. https://doi.org/10.1016/j.eururo. 2017.03.036 [J]. EUROPEAN UROLOGY, 2017, 72 (06) : E157 - E157
- [25] Re: Veerle H. Groen, Karin Haustermans, Floris J. Pos, et al. Patterns of Failure Following External Beam Radiotherapy With or Without an Additional Focal Boost in the Randomized Controlled FLAME Trial for Localized Prostate Cancer. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.12.012 [J]. EUROPEAN UROLOGY, 2022, 81 (06) : E146 - E146
- [26] Re: Kristian D. Stensland, Harras Zaid, Mark Broadwin, et al. Comparative Effectiveness of Treatment Strategies for Squamous Cell Carcinoma of the Bladder. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2018.11.003 [J]. EUROPEAN UROLOGY ONCOLOGY, 2019, 2 (02): : 230 - 230
- [27] Re: Evanguelos Xylinas, Michael Rink, Eugene K. Cha, et al. Impact of Distal Ureter Management on Oncologic Outcomes Following Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2012.04.052 [J]. EUROPEAN UROLOGY, 2012, 62 (05) : E92 - E93
- [28] Re: Meelan Bul, Xiaoye Zhu, Antti Rannikko, et al. Radical Prostatectomy for Low-Risk Prostate Cancer Following Initial Active Surveillance: Results From a Prospective Observational Study. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2012.02.002 [J]. EUROPEAN UROLOGY, 2012, 62 (01) : E9 - E9
- [29] Re: Christopher JD Wallis, Zachary Klaassen, Bimal Bhindi, et al. Comparison of Abiraterone Acetate and Docetaxel with Androgen Deprivation Therapy in High-risk and Metastatic Hormone-naive Prostate Cancer: A Systematic Review and Network Meta-analysis. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2017.10.002 [J]. EUROPEAN UROLOGY, 2018, 73 (03) : E49 - E50
- [30] Re: Loren K. Mell, Stephanie L. Pugh, Christopher U. Jones, et al. Effects of Androgen Deprivation Therapy on Prostate Cancer Outcomes According to Competing Event Risk: Secondary Analysis of a Phase 3 Randomised Trial. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2023.01.020 [J]. EUROPEAN UROLOGY, 2023, 84 (03) : E73 - E74